Sensorineural hearing loss affects nearly 10% of the American population th
at is refractory to conventional therapy. Gene therapy represents an interv
ention with potential therapeutic efficacy. We studied the feasibility of c
ationic liposome mediated gene transfer within the guinea pig cochlea in vi
vo following direct microinjection into the cochlea. Transgene expression w
as persistent up to 14 days in the neurosensory epithelia and surrounding t
issue without toxicity and inflammation in the target organ. This study rep
resents the first successful use of cationic liposomes for cochlear gene tr
ansfer thus providing a safe and rapid alternative to the use of recombinan
t viral vectors in gene therapy for inner ear disorders. (C) 1999 Elsevier
Science B.V. All rights reserved.